-
Symbol
-
CATX on NYSE
-
Investment type
-
Equity / Common Stock, $0.001 par value
-
Latest Disclosed Shares Owned
-
4,461,893 shares
-
Security Ownership %
-
6%
Shares, Excluding Options vs Price
Morgan Stanley ownership in Perspective Therapeutics, Inc. Common Stock, $0.001 par value (CATX)
12 Feb 2026 - Morgan Stanley has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,461,893 shares of Perspective Therapeutics, Inc. Common Stock, $0.001 par value (CATX).
This represents 6% ownership of the company.
This is the first filing by MORGAN STANLEY disclosing ownership of Perspective Therapeutics, Inc. Common Stock, $0.001 par value (CATX).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.